Status:
COMPLETED
Survey of Symptoms After a COVID Vaccination in Employees
Lead Sponsor:
Medical University of Graz
Conditions:
Symptoms Recoding SARS-CoV-2 After Vaccination
Eligibility:
All Genders
16-75 years
Brief Summary
Background: SARS-CoV-2 (Severe acute respiratory syndrome coronavirus type 2) has had us firmly in its grip for more than two years. In January 2021, the quality and risk management unit of the LKH (...
Eligibility Criteria
Inclusion
- Employees with appropriate indication (\>4 months after the second vaccination) according to the recommendations of the national vaccination committee.
- Signed vaccination information sheet.
Exclusion
- no booster vaccination.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
1093 Patients enrolled
Trial Details
Trial ID
NCT06035926
Start Date
January 1 2021
End Date
July 31 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Styria, Austria, 8036